首页

On March 12, Chery’s Jietu Automobile announced today that the new car, known as the "travel off-road super hybrid SUV", will be launched around the Beijing Auto Show in April this year.

In terms of power, Jietu Shanhai T2 is equipped with Chery Kunpeng C-DM hybrid system, equipped with a 1.5TGDI hybrid special engine and a 3-speed DHT gearbox. The maximum power of the engine part is 115 kW, the peak torque is 220 N · m, and the maximum thermal efficiency exceeds 44.5%;

In terms of batteries, the new car is equipped with a pure electric battery life of 208km and a comprehensive battery life of more than 1300km.

In addition, the model is also equipped with a 15.6-inch central control screen, built-in Qualcomm Snapdragon 8155 chip, and supports features such as FOTA smart upgrades.

IT Home Inquiry Jietu official website learned that the length of 4785 mm, width 2006 mm, height 1880 mm, wheelbase 2800 mm, equipped with 1.5TDGI/2.0TDGI engine, 7-speed wet dual-clutch transmission/8-speed AT transmission, the official guide price 13.99-18 4,900 yuan.

　　On January 15, Beijing officially entered the "Two Sessions" time. During the "Two Sessions", the "Citizen Dialogue Leader" series of live interview programs sponsored by the Beijing Municipal Administration of Government Services met with the general public. The guest in the live stream that day was Zhang Jinsong, Secretary of the Party Group and Director of the Beijing Municipal Bureau of Economy and Information Technology. The content of the interview focused on building a new development pattern – strengthening the construction of a global digital economy benchmark city.

　　In 2021, Beijing clearly proposed to build a global digital economy benchmark city. What are the ideas and achievements of Beijing’s construction of a global digital economy benchmark city? How to play the "digital economy" card well to help build a new development pattern for the capital?

　　Building a global digital economy benchmark city

　　Actively build a new pattern of capital development

　　Beijing grasped the general trend of digital economy development and led the way to build a global digital economy benchmark city in July 2021, actively building a new development pattern for the capital. For more than a year, the digital economy has fully empowered industries, cities and lives, and achieved good results. This year’s government work report also proposed to accelerate the construction of a digital economy benchmark city. We need to increase our efforts in this regard.

　　Adhere to the high-level development of digitally empowered industries

　　Vigorously expand emerging digital industries, and the development level ranks among the top in the country. The scale of the city’s artificial intelligence industry exceeds 100 billion yuan, and the number of enterprises also exceeds 1,000, accounting for 29% of the total number of domestic enterprises, ranking first in the country. The development of the blockchain industry also ranks first in the country; the scale of the core industry of the industrial Internet also exceeds 100 billion yuan, and the number of national intelligent manufacturing system solution providers ranks first in the country. Foton Cummins and Sany Heavy Industry were selected as the global "lighthouse factory". Xiaomi’s "black light factory" became the industry benchmark, and the Internet 3.0 started rapidly.

　　High standards for digitally empowered cities

　　Promote the deep integration of the new generation of information technology and urban infrastructure, accelerate the construction of the basic base of the digital city, and 1.296 million users have been connected to the Gigabit fixed network. 75,000 5G base stations have been built, and full coverage within the Fifth Ring Road and precise coverage of key areas and typical scenes outside the Fifth Ring Road have been achieved. The "Seven Links and One Flat" infrastructure building of the smart city has been fully launched, and the next generation of data native infrastructure has been laid out ahead of schedule. The country’s first high-level autonomous driving demonstration area has been built. The advanced deployment of the five systems of the "Vehicle Cloud Network Map" has been completed. Adhere to the orderly progress of "One Network General Office", "One Network Unified Management" and "One Network Smart Governance" to help improve the efficiency

　　Adhere to digital empower life high quality upgrade

　　Promote the construction of a cross-system digital medical demonstration center, introduce new technology pilots such as artificial intelligence and intelligent perception in scenarios such as Internet diagnosis and treatment, smart hospital construction, and chronic disease management; build a lighthouse community, accelerate the layout of sub-center community demonstration projects, and promote the overall butler service model; expand new forms of digital consumption, cultivate and form 15 information consumption experience centers, and during the 2022 Beijing Digital Economy Experience Week and Digital Consumption Festival, the cumulative consumption of digital consumption reached nearly 7 billion yuan.

　　Constantly seize new opportunities

　　Helping multiple "new tracks" rise rapidly

　　Zhang Jinsong mentioned that Beijing continues to seize new opportunities for the development of the digital economy and realize the development and rise of multiple "new track" pilot industries. As the main force of economic development, enterprises will have more opportunities for innovation and transformation.

　　The first is to develop a new generation of travel industries such as autonomous driving, vehicle-road collaboration, and shared travel, and promote the organic penetration and integration of the traditional transportation industry and the Internet to build a new generation of digital travel networks.

　　The second is to support Beijing Financial Institutions Group to build financial formats and service systems based on Internet platforms, and to innovate financial business models such as banking, insurance, and securities.

　　The third is to use AI technology, big data, cloud computing and other intelligent technologies and new-generation information technologies to integrate the medical and health field, promote the upgrading and optimization of traditional medical services, create a new business model of the digital health service industry, and promote the construction of a cross-system digital medical demonstration center to form a trend of agglomeration and development of the digital health service industry.

　　The fourth is to promote digital consumption, encourage Wangfujing, CBD and other traditional business districts, create a demonstration digital business district pilot, launch the "quarter-hour convenient life circle dynamic map", and carry out big data monitoring and analysis, accurate replenishment and standardization of more than 90,000 convenient business outlets in the city.

　　Strengthen the "five sons" linkage

　　Make new contributions to the development of the capital in the new era

　　Strengthening the linkage of the "five sons" is an effective path for Beijing to take the lead in building a new development pattern, an important breakthrough point for implementing the strategic positioning of the "four centers", and a strong driving force for the high-quality construction of a global digital economy benchmark city; the construction of a global digital economy benchmark city is closely related to and mutually supportive of other "four sons".

　　Leading the capital’s benchmark city with digital technology innovation

　　Form an autonomous and controllable technology system

　　Focusing on "stuck neck" and cutting-edge core technologies, exploring and improving the new national system, building a common technology platform, and initially taking shape a digital technology innovation system with independent control, integrated Product R & D, and soft and hard coordination; major breakthroughs and developments have been made in high-end chips, basic software and hardware, networks, security, artificial intelligence, blockchain and other fields.

　　The Pilot Practice of Boosting the Construction of "Two Districts" with the Opening of the Whole Digital Industry Chain

　　Make full use of the advantages of the "two regions" ‘first-mover and first-mover policies, deepen institutional innovation and policy integration in advantageous areas such as scientific and technological innovation, digital economy, and service industry opening, and strengthen international cooperation in the digital field. Successfully held 2 Global Digital Economy Conferences, turning the Global Digital Economy Conference into an international open exchange platform for national policy release, digital economy frontier technology exchange, digital application display and promotion, and major project introduction.

　　Driving the Construction of an International Consumption Center City with Digital Consumption

　　Vigorously develop online consumption, strive to create new scenarios for digital consumption, support the digital transformation of traditional business districts, build smart business districts in key areas such as commercial blocks and scenic spots, improve the supply level of digital consumption, and promote the sustainable and healthy development of new digital consumption models such as e-commerce, live broadcast economy, and online entertainment.

　　To empower the coordinated development of Beijing-Tianjin-Hebei with the collaborative depth of the digital industrial chain

　　Beijing-Tianjin-Hebei signed the "Framework Cooperation Agreement on Building the Beijing-Tianjin-Hebei Industrial Internet Collaborative Development Demonstration Zone", established the "Beijing-Tianjin-Hebei Industrial Internet Collaborative Development Working Group", launched the Industrial Internet Data Element Registration Platform, and jointly created an industrial Internet innovation ecosystem based in Beijing-Tianjin-Hebei and radiating to the whole country.

　　Research and explore the reform and development model

　　Make every effort to promote the development of the digital economy industry

　　On January 1 this year, the "Regulations of Beijing Municipality on the Promotion of Digital Economy" were officially implemented. The promulgation of the "Regulations" established a "new beacon" for the development of Beijing’s digital economy. At the same time, it also provided legal protection for the city to accelerate the construction of a global digital benchmark city. The "Regulations" carry out top-level system design around digital infrastructure, data resources, digital economy industries, smart city construction, digital economy safety and security.

　　In the next step, we will deeply implement the spirit of the 20th National Congress of the Communist Party of China and the Central Economic Work Conference, study and explore the development model of digital economy reform, improve the digital economy governance system, focus on promoting digital technology innovation, and accelerate new infrastructure buildings such as smart cities and data natives. Grasp the benchmarking project and drive the benchmarking industry. On the one hand, accelerate the promotion of digital industrialization, support the basic research and key technology research of the digital industry, focus on cultivating high-end chips, basic software and hardware, Xinchuang, artificial intelligence, blockchain, Internet 3.0 and other core industries of the digital economy, and promote the healthy development of the platform economy. On the other hand, accelerate the digitalization of the industry, support the development of the Internet in the fields of agriculture, manufacturing, construction, energy, finance, medical care, education, circulation and other industries, and establish a state-owned enterprise digital transformation benchmark.

Titanium Media Note:This article comes from WeChat official account eight points health news (ID: HealthInsight), author: Wu Yeting, editor in charge: Wang Jilu, titanium media authorized to publish.

In more than a month, 21 trading limits, the stock price rose from 8.75 yuan to 84.82 yuan, an increase of nearly 9 times, and it has not stopped, Wantai Bio is likely to become the most rising new stock in 2020. This is also far more than the 16 trading limits of WuXi PharmaTech in 2018 and the increase of nearly 5 times.

Along with the stock price, there is the value of the actual controller Zhong Shanshan, whose shares in Wantai Bio have reached 27.60 billion yuan. In September 2001, he spent 17.10 million yuan to buy 95% of the shares in Wantai Bio, which has increased by 1600 times in 19 years. And the low-key Zhong Shanshan, the most well-known commercial version of the picture, is about to be listed on the Hong Kong Stock Exchange. It is estimated that the market value will be 100 billion after the listing, and the wealth of Zhong Shanshan will exceed 100 billion.

Wantai Bio was established in 1991 as a Sino-Japanese joint venture. Since then, its shares have been converted several times, and its main business has remained unchanged. It is mainly engaged in the research and development, production and sales of in vitro diagnostic reagents, in vitro diagnostic instruments and vaccines.

Although the main business is vaccines, Wantai Bio’s first vaccine was developed in 1998 and did not go on sale until 2012. Moreover, this is a hepatitis E vaccine. Its sales revenue in 2019 was only over 14 million, accounting for less than 2%.

To this year, the first real market prospects of the main product, from 2003 began to develop the 2-valent human papillomavirus vaccine (HPV vaccine, cervical cancer vaccine) Xin Kening (Cecolin) before the market, and Wantai biological investment in research and development costs have exceeded 1.10 billion yuan, it can be seen that the pharmaceutical industry really needs time and capital to temper.

Wantai Bio’s Xinkoning is the third HPV vaccine in the world, which was approved on the same day, as well as Watson Bio’s 13-valent pneumococcal polysaccharide conjugate vaccine, which is China’s first 13-valent pneumonia vaccine. Pfizer’s annual sales are $5.80 billion. After the COVID-19 pandemic broke out, Kanginuo and Kexing Bio were in the first sequence of global COVID-19 vaccine development.

So, is China’s vaccine industry starting to shift from the sales-driven trend of the past to the trend of emphasizing R & D and paying attention to both legs? Is the popularity of Wantai Bio a projection of the industry emerging from the shadows after the "vaccine crisis" in 2018, or a capital hype for vaccine stocks under the COVID-19 pandemic?

Since landing on the main board of the Shanghai Stock Exchange on April 29, Wantai Bio has stably maintained the rhythm of the daily limit of each trading day, and by June 1, it has continuously harvested 21 one-word daily limit boards.

Up to now, the record of new shares listed on the main board of the Shanghai Stock Exchange this year is the Star Semiconductor listed in February, which has achieved 22 one-word daily limit. Followed by Wantai Bio, and Wantai Bio has not yet opened the board and is expected to break the record.

And pushing the time forward to a longer cycle, according to Wind data statistics, since the implementation of the first day of listing restrictions on new shares in 2014, a total of 51 new shares have exceeded 20 after listing. After Jucan Optoelectronics, which listed in October 2017, Star Semiconductor and Wantai Bio are the only two new shares that have reached 20 one-word boards in more than two years. Also in the pharmaceutical field, the last one with the largest number of boards was WuXi AppTec, which listed in 2018. After 16 one-word boards, it rose from 21.6 yuan to 92.91 yuan.

According to the data disclosed in the prospectus, Wantai Bio achieved revenue of 949 million, 983 million yuan and 1.184 billion yuan in 2017, 2018 and 2019 respectively, the largest proportion of which is diagnostic reagents. However, this composition is about to change. Wantai Bio’s HPV vaccine has been officially listed in May this year, and the company expects sales revenue to usher in explosive growth.

Since the outbreak of the COVID-19 pandemic, Wantai Bio, together with the National Research Center for Infectious Disease Diagnostics and Vaccine Engineering Technology (NIDVD) of Xiamen University, has developed 11 detection reagents such as the novel coronavirus antibody detection kit (double antigen sandwich method), and invested in the research and development of the recombinant protein new coronavirus vaccine candidate (COVID-19XWG-03).

Detection kits and vaccines related to COVID-19 are an important reason for the continuous rise of Wantai, a securities analyst to eight health news analysis, detection and vaccine are two important concepts involved in Wantai, the former product quality has been internationally recognized, exported to many countries; the latter because the final can be completely against the novel coronavirus will be the vaccine, and the companies involved in the development of COVID-19 vaccines, including Wantai Bio, have a certain degree of overgrowth.

In vitro diagnostics and vaccines are the core business of Wantai Bio.

In vitro diagnosis refers to a diagnostic method that obtains clinical diagnostic information by testing human samples (blood, body fluids, cells, tissues, etc.) outside the human body. Internationally, it is collectively referred to as IVD (In-Vitro Diagnostics). During the COVID-19 pandemic, nucleic acid testing with pharyngeal swab sampling is an in vitro diagnostic method.

According to its prospectus, Wantai Bio has formed characteristic testing products in AIDS, hepatitis, tuberculosis, dengue virus, etc. In 2019, diagnostic reagents and diagnostic instruments generated 1.20 billion yuan of business income for Wantai, accounting for more than 80%.

Compared with in vitro diagnostics, vaccine research and development requires more investment and takes longer to develop and market. The current R & D pipeline includes recombinant hepatitis E vaccine, bivalent cervical cancer vaccine, nine-valent cervical cancer vaccine, next-generation cervical cancer vaccine, and freeze-dried varicella live vaccine, of which only the first two have been approved for marketing.

In the prospectus, Wantai attributed its core competitiveness to its research and development capabilities. As of the end of 2019, the company had a research and development team of 382 people, accounting for 21.41% of the total number of employees.

In addition, Wantai Bio and Xiamen University jointly established the National Infectious Disease Diagnostic Reagents and Vaccine Engineering Technology Research Center, and maintained close cooperation with the team of Xia Ning Shao, Dean of the School of Public Health of Xiamen University.

During the reporting period, the R & D expenses invested by Wantai were 159 million yuan, 138 million yuan and 166 million yuan respectively, accounting for about 15% of the operating income.

This proportion is relatively high in the industry, but it is still not high compared to the nearly 30% of sales expenses.

After the outbreak of the epidemic, Wantai Bio invested in the development of COVID-19 antibody detection kits and COVID-19 vaccines.

In March, the novel coronavirus antibody detection kit (chemiluminescent microparticle immunoassay) was approved by the State Drug Administration on an emergency basis, becoming one of the five novel coronavirus antibody detection reagents that had been approved at that time. Since then, Wantai Bio has developed 11 detection reagents such as the novel coronavirus antibody detection kit (double antigen sandwich method) in conjunction with the National Infectious Disease Diagnostic Reagents and Vaccine Engineering Technology Research Center (NIDVD) of Xiamen University. As of March 30, Wantai Bio has supplied 437,000 detection reagents in China and 502,000 abroad.

According to the information disclosed by Wantai, the product uses a double antigen sandwich method to detect the total antibodies of novel coronavirus in blood samples (including various antibody types such as IgM, IgG and IgA), which methodologically guarantees that the reagent has higher sensitivity and better specificity, and reduces the false positive rate. Since then, several novel coronavirus antibody detection kits developed by Wantai have been certified by the European Union CE and exported to South Korea, Italy, Hungary, Austria, the Netherlands and other countries.

On April 2, Wantai Bio and GlaxoSmithKline (GSK) jointly announced that they have cooperated in the development of novel coronavirus. But at present, compared with other COVID-19 vaccines under development, Wantai Bio has fallen behind.

The launch of the HPV vaccine is a milestone for Wantai Bio.

According to its prospectus, as the third cervical cancer vaccine supplier in the world and the first domestic HPV vaccine to be launched in China, Wantai expects to lead its domestic peers by about two years.

This market is very large, according to Wantai’s calculation, the current domestic cervical cancer vaccination for women aged 9-45 a total of about 300 million people, according to the domestic cervical cancer vaccine price for imported vaccines 1/2 (about 300 yuan/dose, 900 yuan/person) calculation, the stock market size up to 270 billion yuan, according to 1% vaccination rate estimated market demand is 2.70 billion yuan.

Cervical cancer vaccines currently available on the market are divided into bivalent, quadrivalent, and nine-valent. The higher the number, the more virus types that can be prevented. The overall protective efficacy of the bivalent vaccine against cervical cancer prevention is 84.5%, and the overall protective efficacy of the nine-valent vaccine is 92%.

The price and young age group are the advantages of Wantai’s bivalent vaccine, which is priced at 329 yuan/shot. The whole process of vaccination between 9 and 14 years old requires two shots, or 658 yuan; for those over 14 years old, the whole process requires three shots, or 987 yuan. The bivalent vaccine of GSK is 580 yuan/shot, and the whole process costs 1,740 yuan for three shots. Merck’s quadrivalent and nine-valent vaccines are 798 yuan/shot, 1,298 yuan/shot, respectively. Three shots cost 2,394 yuan and 3,894 yuan.

In the past May, Xinkening has been officially launched, and ads for domestic HPV vaccines can be seen on Alipay.

However, there are also pessimistic expectations for market demand. Zhao Heng, founder of Latitude Health, a medical strategy consulting firm, said in an interview with Time Finance that the bivalent cervical cancer vaccine of Wantai Bio will not cause major changes to the current domestic market structure, because the consumption attribute of cervical cancer vaccine is stronger, and consumers prefer the nine-valent, and the advantages of the bivalent cervical cancer vaccine are weaker.

Xiamen University, a partner of Wantai Bio, previously said that the first batch of launch areas are Hubei, Xinjiang, Jilin, Yunnan, Jiangsu, Shandong and other provinces. From this market layout, it can avoid head-to-head confrontation with Merck and GSK to a certain extent, and open the second- and third-tier cities with cost-effectiveness.

In addition to the 2-valent vaccine, the 9-valent HPV vaccine is also in Wantai’s research and development plan. It was approved in 2017 and completed the Phase 1 clinical trial in 2019. It has now entered the Phase 2 clinical trial, ahead of other domestic companies.

It is worth mentioning that Wantai’s research and development technology on HPV vaccines can help improve the protection rate of 9-valent vaccines from 92% to 99%, which has been recognized by GSK, a leading company in the industry. It will pay a total of 134 million euros to Wantai Bio (about 1 billion yuan), use Wantai’s HPV vaccine antigen technology to develop new cervical cancer vaccines, and share the international market sales revenue with Wantai. In November 2019, Wantai received the first milestone payment of 11 million euros (about 85 million yuan).

For many years, China’s vaccine industry has been sales-driven.

In an article, Junlin Investment Research Institute described China’s vaccine industry as: a typical "two legs one big and one small walk" driving model, research and development is the calf, sales is the thigh, because the early research and development costs are high and the later production costs are low, only the more sold, can quickly return to the cost, and generate several times the profit of revenue growth. So whoever can sell the vaccine and earn back the white ocean will have a high status. In a typical vaccine company, Jiang Rensheng of Zhifei Bio has a sales background, Du Weimin of Kangtai Bio has a sales background, Gao Junfang of Changsheng Bio has a financial background, her husband and vice president Zhang Youkui has a sales background, and Li Yunchun, chairperson of Watson Bio, also has a sales background.

The advantage of sales-driven is that it can generate quick cash flow, which is conducive to promoting research and development and launching new vaccines.

For example, Changsheng Bio had a sales cost of 583 million yuan in 2017, and there were 25 sales staff, and the per capita annual sales cost exceeded 23 million. Many cases involving vaccine distributors bribing CDC staff can be found in the judgment document network.

The sales of Wantai biological pre-vaccine are relatively small, but in the sales of testing reagents, the company was also involved in a case of bribery by the director of the hospital’s laboratory department. The company’s overall sales expenses also accounted for a high proportion, approaching 30%.

While focusing on sales, if the product is light, it is prone to problems. Extreme cases are like the Changsheng Biological Vaccine incident in 2018, which pushed substandard vaccines to the market.

After the incident, the vaccine industry was mired in a crisis of confidence and was facing a reshuffle.

At the end of Product Research & Development, good news has come one after another. On December 31, 2019, Wantai Bio’s HPV vaccine and Watson Bio’s 13-valent pneumonia vaccine were approved at the same time, providing room to compete with imported vaccines in these two fields. In the research and development competition of COVID-19 vaccines, more than 130 projects around the world, Kang Xinuo’s adenovirus vector vaccine and Koxing Bio’s inactivated vaccine, are the first to enter clinical trials.

However, the newly approved vaccine, after the listing of the feedback is still unknown. Wantai Bio’s hot market, and the overall rise in the biomedical industry under the epidemic is also related, according to the wind sub-industry index, if the latest index data compared with the beginning of the year to calculate the increase, health care social security and supplies index (50.65%), biotechnology index (45.37%), life science tools and services index (26.01%) are ranked high, like Kang Xinuo’s stock, also rose 3 times at the peak.

Whether China’s vaccine industry will shift from sales-driven to a model that places equal emphasis on sales and research and development is still uncertain. But change is happening.

On May 31st, Wenjie new M7 Ultra was officially listed. At the press conference, Hongmeng Zhihang handed over the latest answers to a number of products – Wenjie new M5 was listed for 1 month and will break through 20,000 units; Zhijie S7 ranked NO.3 in the April delivery volume of 300,000 + pure electric cars; Wenjie M9 was listed for 5 months and will break through 90,000 units. Among them, as the sales and quality double champion of China’s high-end luxury SUV market, Wenjie new M7 was listed for 8 months and will break through 180,000. The listed Wenjie new M7 Ultra is updated with "extraordinary driving control, extraordinary safety, extraordinary wisdom and extraordinary space", which will bring users a more outstanding travel experience and help Hongmeng Zhihang family sales continue to rise.

At the press conference, Yu Chengdong, executive director of Huawei, chairperson of end point BG, and chairperson of smart car solutions BU, said: "The new M7 Ultra brings four major upgrades, and the increase in volume does not increase the price! The appearance is more pleasing to the eye, the chassis performance is stronger, the smart driving ability and safety ability are higher, and the sound effect is more shocking, which will allow more users to enjoy the high-end and ultimate travel experience. It is a well-deserved’national SUV ‘in the era of smart cars!"

The new family design, the flagship style of the road to simplicity

The new M7 Ultra shows its new temperament in a family-style design language. The front face shape adopts a more delicate grille design, presenting a more complete profile and giving the whole vehicle a stronger sense of technology. The new M7 Ultra comes standard with a new 20-inch double seven-spoke star-twinkling wheel hub, which is more beautiful. At the same time, it can be equipped with a 21-inch double ten-spoke sports wheel hub, which is full of aura.

The new M7 Ultra offers 5 exterior colors and 3 interior color schemes. Including ice crystal silver, deep space gray, azure blue and gilt black, the new interstellar blue (optional) body color scheme highlights the high-end texture and technological luxury of the flagship homologous. The interior color comes standard with Shaohua apricot and amber brown, and the new red tea orange interior can be selected to bring more dynamic choices to consumers.

Newly upgraded 192-line lidar makes smart driving safer and stronger

The newly upgraded flagship 192-line lidar of the new M7 Ultra has more powerful accurate detection and fast response capabilities, with a maximum detection distance of 250m and an industry-leading scanning frequency of 20Hz. At the same time, with more powerful software and hardware coordination capabilities, the new M7 Ultra realizes more comprehensive intelligent safety protection and easier intelligent driving experience.

The omnidirectional anti-collision ability of Wenjie’s new M7 Ultra has been further advanced, achieving "no one has me, and no one has me". The effective range of forward active safety AEB has been increased to 4-150km/h, and the braking speed in stationary vehicle scenes has been increased to 120km/h; lateral active safety can be actively recognized as drainage horses, cones, roadsides, pedestrians and vehicles, and the effective range has been increased to 40-130km/h; backward active safety can actively identify pedestrians, vehicles and two-wheelers, and the effective range has been increased to 1-60km/h. From September 2023 to May 2024, the new M7 actively avoids more than 80,000 possible collisions (Note: This function is only for auxiliary driving and cannot replace driver control. Drivers need to maintain necessary attention at all times and intervene in a timely manner according to the surrounding environment), effectively reducing the risk of accidents for users.

As of May 2024, HUAWEI ADS 2.0 high-level intelligent driving system continues to evolve, urban NCA pilot has covered more than 40,000 cities and towns across the country, the total mileage of intelligent driving has reached 220 million kilometers, and the computing power of cloud learning and training has been increased to 3.5E FLOPS.

Newly upgraded CDC variable damping shock absorber, more luxurious driving texture

The new M7 Ultra has newly upgraded the CDC continuous variable damping shock absorber, and the driving experience has been fully upgraded. The chassis suspension provides three adjustable modes. For different usage scenarios, the shock absorber can realize information transmission within 10 milliseconds, and the adjustment frequency can reach 100 times/second. At the same time, the CDC can independently control the corresponding wheel vibration damping, actively suppress the fluctuation of the body posture, make the corners smoother, start and stop silkier, and effectively improve the driving comfort and driving stability.

Relying on Huawei’s hardcore technology, the M7 Ultra realizes the intelligent coordination ability of ADS preview and CDC shock absorber automatic adjustment. During vehicle driving, the M7 Ultra can intelligently identify the speed bumps on the road, adjust the damping of the shock absorber in advance, "soft up and hard down" to reduce the impact feeling and optimize the driving experience. In addition, with this software and hardware upgrade, as well as the adjustment skills of Huawei German Research Institute, the test result of the M7 Ultra Elk has been improved to 75.5km/h, effectively improving the stability and safety of driving control.

The new M7 Ultra is equipped with the HUAWEI DriveONE extended range electric drive platform, and the four-wheel drive version has a zero-hundred acceleration of 4.8s, leading the same level in power performance. Under the condition of full oil and full power CLTC, the new M7 has a comprehensive battery life of 1300km, achieving a long range without worry.

New luxury texture cockpit, ever-changing magic space upgraded again

Ask the world to upgrade the new M7 Ultra magic space, the new ring scatter is integrated into Schroeder acoustic scattering technology, the sound diffusion angle is increased by 2.5 times, the balance is increased by 40%, and the sound effect ? HUAWEI SOUND is more shocking and the listening is more immersive. At the same time, the ring scatter can be linked with the ambient light, making the interaction more ceremonial and the good sound visible. Combined with HUAWEI Maglink ? convenient and re-upgrade, the magic magnetic attraction can be removed and combined, and it is suitable for a variety of sizes of tablets (some configurations need to be optional and purchased separately, and the actual product delivery shall prevail) to achieve front and rear screen interaction and entertainment creation.

The new five-seat version of Wenjie M7 Ultra has the largest 3338mm effective space in the car in the same class, as well as oversized one-row, two-row and trunk space, easily meeting the travel needs of the whole family. The newly upgraded Shuyun seat, Nappa leather is more skin-friendly to the touch (only one and two rows of cushions and backrests are Nappa leather), the seat is softer, supports and fits better, making every seat like immersed in soft clouds. With Shuyun headrest, it brings a more comfortable and ultimate riding experience.

In terms of space flexibility, the new M7 Ultra has upgraded the main driver’s music headrest with a pluggable design. The front seat backrest can be reclined 69 °, and the depth after docking with the rear seat cushion can reach a maximum of 3m, achieving a beach chair mode where two people can easily lie flat, and can also be flexibly changed to a single bed or a double bed mode. At the same time, the two-row zero-gravity seat with six seats has a new anti-pinch function, with a larger adjustable angle and more detailed care for passengers.

In terms of price rights and interests, the official guide price of the new M7 Ultra series is: the new M7 Ultra five-seat rear drive smart driving version 289,800 yuan, the new M7 Ultra five-seat four-wheel drive smart driving version 309,800 yuan, the new M7 Ultra six-seat rear drive smart driving version 309,800 yuan, and the new M7 Ultra six-seat four-wheel drive smart driving version 329,800 yuan. The first batch of users who order before 23:59:59 on June 30 can enjoy the purchase rights and interests of up to 35,000 yuan, including a gift of 3,000 yuan in cash (only available to deduct the last payment of the car purchase), a gift of 12,000 yuan in matching gold (which can be used to deduct the interior, appearance and wheel hub. If it is not selected or the matching amount is lower than the equity amount, it will be reduced by the actual matching amount), and a gift of 20,000 yuan in ADS high-end function package subsidy rights (which can be used to deduct part of the ADS high-end function package. The valid period of this right is within 30 days from the date of delivery of the vehicle). Wenjie New M7 Ultra will be available as soon as it is listed, and the order will be opened immediately. It will be officially delivered in batches from June 2.

At this press conference, the first blockbuster product of the STELATO Enjoy brand, the Panorama Smart Flagship S9, opened for pre-sale. As the first executive-level luxury flagship sedan of Hongmeng Zhixing, the Enjoy S9 not only has the lowest wind resistance of the world’s mass-produced executive luxury sedan, but also reshapes the luxury experience in a new space based on Huawei’s intelligent precipitation. In addition, the new car also has surging power beyond traditional luxury, equipped with the latest Turing platform, and launched HUAWEI ADS 3.0 high-end intelligent driving system and other intelligent technologies, all-round reshaping of executive luxury.

The pre-sale price of Enjoy S9 is 450,000 yuan – 550,000 yuan. Now you can double the intention fee (5,000 yuan to 10,000 yuan) and give priority to delivery. It is reported that Enjoy S9 will be listed at the Guangdong-Hong Kong-Macao Greater Bay Area International Automobile Expo and will be officially listed in Beijing in August.